bene-Arzneimittel GmbH
Clemens Weigel is a QA Manager and Lead Investigator at bene-Arzneimittel GmbH since June 2023, bringing extensive quality assurance expertise from prior roles at Bristol Myers Squibb as a Specialist and Associate Specialist in Quality Assurance from December 2020 to June 2023. Previous experience includes positions at Juno Therapeutics, Inc. as an Associate Specialist in Manufacturing and Manufacturing Technician, and a role as Verfahrenstechniker at top itservices AG. Clemens Weigel began a career in fermentation as an Engineer at Clariant, focusing on sunliquid Bioethanol from December 2013 to August 2017. Educational qualifications include a Diplom-Ingenieur degree in Brauwesen & Getränketechnologie from Technical University of Munich and training as a Brauer & Mälzer from Kulmbacher Brauerei AG.
This person is not in any teams
bene-Arzneimittel GmbH
bene-Arzneimittel GmbH is a medium-sized pharmaceutical company focused on analgesic, paediatric and urological medicines. As the pioneer of paracetamol in Germany bene has a long lasting competence in treating children and other sensitive patient groups. Beyond that, bene offers unique and innovative pharmaceuticals e.g. with the active ingredient pentosan polysulphate. Today, bene-Arzneimittel GmbH develops, produces and sells a balanced range of medicinal products and medical devices to the German market and selected countries worldwide.